glp 1 tinnitus Understanding GLP-1 Medications and The Risk of Vestibular Disorders
Description
Diabetes Obes Metab (2018) 20(2):35261
placebo with respect to resolution of MASH without worsening of fibrosis [136, 137]
Adverse effects Since the GLP-1 agonists (semaglutide) have been approved for weight loss therapy, a new era for obesity management has developed rapidly
doi: 10.1007/s00125-008-1195-5
Zubair, M., El Sharu, H., & Launico, M
